Emory Vaccine Center, Division of Microbiology and Immunology, Yerkes Research Primate Center, Emory University School of Medicine, Atlanta, Georgia.
Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia; Emory Antibiotic Resistance Center, Atlanta, Georgia.
Gastroenterology. 2018 Jun;154(8):2178-2193. doi: 10.1053/j.gastro.2018.02.019. Epub 2018 Feb 15.
BACKGROUND & AIMS: Variants at the ABCB4 or MDR2 locus, which encodes a biliary transport protein, are associated with a spectrum of cholestatic liver diseases. Exacerbation of liver disease has been linked to increased hepatic levels of interleukin (IL) 17, yet the mechanisms of this increase are not understood. We studied mice with disruption of Mdr2 to determine how defects in liver and alteration in the microbiota contribute to production of IL17 by intrahepatic γδ T cells.
We performed studies with Mdr2 and littermate FVB/NJ (control) mice. IL17 was measured in serum samples by an enzyme-linked immunosorbent assay. Mice were injected with neutralizing antibodies against the γδ T-cell receptor (TCR; anti-γδ TCR) or mouse IL17A (anti-IL17A). Livers were collected and bacteria were identified in homogenates by culture procedures; TCRγδ cells were isolated by flow cytometry. Fecal samples were collected from mice and analyzed by 16S ribosomal DNA sequencing. Cells were stimulated with antibodies or bacteria, and cytokine production was measured. We obtained tissues from 10 patients undergoing liver transplantation for primary sclerosing cholangitis or chronic hepatitis C virus infection. Tissues were analyzed for cytokine production by γδ TCR cells.
Mdr2 mice had collagen deposition around hepatic bile ducts and periportal-bridging fibrosis with influx of inflammatory cells and increased serum levels of IL17 compared with control mice. Administration of anti-IL17A reduced hepatic fibrosis. Livers from Mdr2 mice had increased numbers of IL17A γδTCR cells-particularly of IL17A Vγ6Jγ1 γδ TCR cells. Fecal samples from Mdr2 mice were enriched in Lactobacillus, and liver tissues were enriched in Lactobacillus gasseri compared with control mice. Mdr2 mice also had increased intestinal permeability. The γδ TCR cells isolated from Mdr2 livers produced IL17 in response to heat-killed L gasseri. Intraperitoneal injection of control mice with L gasseri led to increased serum levels of IL17 and liver infiltration by inflammatory cells; injection of these mice with anti-γδ TCR reduced serum level of IL17. Intravenous injections of Mdr2 mice with anti-γδ TCR reduced fibrosis; liver levels of IL17, and inflammatory cells; and serum levels of IL17. γδTCR cells isolated from livers of patients with primary sclerosing cholangitis, but not hepatitis C virus infection, produced IL17.
In Mdr2 mice, we found development of liver fibrosis and inflammation to require hepatic activation of γδ TCR cells and production of IL17 mediated by exposure to L gasseri. This pathway appears to contribute to development of cholestatic liver disease in patients.
编码胆汁转运蛋白的 ABCB4 或 MDR2 基因座的变异与一系列胆汁淤积性肝病有关。肝疾病的恶化与肝内白细胞介素 (IL) 17 水平升高有关,但这种增加的机制尚不清楚。我们研究了 Mdr2 基因敲除小鼠,以确定肝脏缺陷和微生物组改变如何导致肝内 γδ T 细胞产生 IL17。
我们对 Mdr2 和同窝 FVB/NJ(对照)小鼠进行了研究。通过酶联免疫吸附试验(ELISA)测量血清样本中的 IL17。用抗 γδ TCR(抗-γδ TCR)或小鼠 IL17A(抗-IL17A)的中和抗体对小鼠进行注射。收集肝脏并通过培养程序鉴定肝匀浆中的细菌;通过流式细胞术分离 TCRγδ 细胞。收集小鼠粪便样本并通过 16S 核糖体 DNA 测序进行分析。用抗体或细菌刺激细胞,并测量细胞因子的产生。我们从 10 名接受原发性硬化性胆管炎或慢性丙型肝炎病毒感染肝移植的患者中获得组织。通过 γδ TCR 细胞分析组织中细胞因子的产生。
与对照小鼠相比,Mdr2 小鼠的肝脏胆管周围有胶原沉积,门管区周围有桥接纤维化,炎症细胞浸润增加,血清中 IL17 水平升高。给予抗 IL17A 可减少肝纤维化。Mdr2 小鼠的肝脏中 IL17A γδTCR 细胞数量增加-尤其是 IL17A Vγ6Jγ1 γδ TCR 细胞。与对照小鼠相比,Mdr2 小鼠的粪便样本富含乳杆菌,而肝脏组织富含乳杆菌 gasseri。Mdr2 小鼠还存在肠道通透性增加。从 Mdr2 肝脏中分离出的 γδ TCR 细胞在热灭活 L gasseri 的刺激下产生 IL17。向对照小鼠腹腔内注射 L gasseri 可导致血清中 IL17 水平升高和炎症细胞浸润肝脏;向这些小鼠注射抗 γδ TCR 可降低血清中 IL17 水平。静脉注射 Mdr2 小鼠抗 γδ TCR 可减少纤维化;肝脏中 IL17、炎症细胞和血清中 IL17 的水平。从原发性硬化性胆管炎患者的肝脏中分离出的 γδTCR 细胞,但不是丙型肝炎病毒感染患者的 γδTCR 细胞产生 IL17。
在 Mdr2 小鼠中,我们发现肝纤维化和炎症的发展需要肝脏激活 γδ TCR 细胞,并通过暴露于 L gasseri 介导的 IL17 产生。该途径似乎有助于患者发生胆汁淤积性肝病。